4.6 Article

Epigenetic signature associated with thyroid cancer progression and metastasis

Journal

SEMINARS IN CANCER BIOLOGY
Volume 83, Issue -, Pages 261-268

Publisher

ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
DOI: 10.1016/j.semcancer.2021.03.026

Keywords

microRNA; Thyroid cancer; Epigenetic signature; Non-coding RNA; Metastasis

Categories

Funding

  1. Scientific and Technological Devel-oping Scheme of Ji Lin Province [20180623020TC]

Ask authors/readers for more resources

Thyroid cancer has become more prevalent in women and young adults in recent years. MicroRNAs (miRNAs) have been identified as potential epigenetic markers for thyroid cancer progression and metastasis, offering potential therapeutic targets.
Thyroid cancer is not among the top cancers in terms of diagnosis or mortality but it still ranks fifth among the cancers diagnosed in women. Infact, women are more likely to be diagnosed with thyroid cancer than the males. The burden of thyroid cancer has dramatically increased in last two decades in China and, in the United States, it is the most diagnosed cancer in young adults under the age of twenty-nine. All these factors make it worthwhile to fully understand the pathogenesis of thyroid cancer. Towards this end, microRNAs (miRNAs) have constantly emerged as the non-coding RNAs of interest in various thyroid cancer subtypes on which there have been numerous investigations over the last decade and half. This comprehensive review takes a look at the current knowledge on the topic with cataloging of miRNAs known so far, particularly related to their utility as epigenetic signatures of thyroid cancer progression and metastasis. Such information could be of immense use for the eventual development of miRNAs as therapeutic targets or even therapeutic agents for thyroid cancer therapy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available